Status:
UNKNOWN
Cost-Effectiveness in Bladder Cancer
Lead Sponsor:
Erasmus Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Reinier de Graaf Groep
Conditions:
Bladder Cancer
Eligibility:
All Genders
Brief Summary
This randomized clinical multicentre trial aims to evaluate the efficacy of microsatellite analysis on voided urine to detect tumour recurrences in the follow-up of patients with superficial urothelia...
Detailed Description
The randomized clinical study consists of two intervention arms. The control arm consists of a conventional follow-up based on regular monitoring for urinary bladder UCC recurrences by cystoscopy. In ...
Eligibility Criteria
Inclusion
- All patients with resectable pT1 or pTa, grade G1-G2 transitional cell carcinoma of the bladder which is biopsy proven
Exclusion
- Patients who present or presented with a transitional cell carcinoma of the bladder, stage pT2 or more invasive, or carcinoma in situ (CIS) and/or G3 diagnosed in history
Key Trial Info
Start Date :
July 1 2002
Trial Type :
OBSERVATIONAL
End Date :
July 1 2005
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00126958
Start Date
July 1 2002
End Date
July 1 2005
Last Update
February 19 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.